US Stock MarketDetailed Quotes

KMPH KemPharm

Watchlist
  • 5.810
  • 0.0000.00%
15min DelayClose Feb 28 16:00 ET
200.47MMarket Cap-6528P/E (TTM)

KemPharm Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

KemPharm Earnings Date

Currency: USD

Period

Q3 FY2022 Earnings

Nov 9, 2022

Revenue(YoY)

2.87M

+46.26%
EPS(YoY)

-0.19

-280.00%
Analyst Rating

No Data

KemPharm Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 5.447M--
--2024/Q2-- / 4.407M--
--2024/Q13.425M / 3.759M--
--2023/Q413.217M / 11.738M--
--2023/Q32.895M / 3.379M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 5.447M--
--2024/Q2-- / 4.407M--
--2024/Q13.425M / 3.759M--
--2023/Q413.217M / 11.738M--
--2023/Q32.895M / 3.379M--

Unlock Free Earnings Estimates

KemPharm Earnings Reports

  • 10-Q: Quarterly report

    May 9 16:38 ET

  • KemPharm | 10-K: Annual report

    Apr 1 17:33 ET

  • KemPharm | 10-Q: Quarterly report

    Nov 7, 2023 17:23 ET

  • KemPharm | 10-Q: Quarterly report

    Aug 14, 2023 16:34 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg